Trailing-twelve-month (TTM) revenue is $5.69 Billion with a year-over-year growth of +10.18%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-08-31 | $1,330,975,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q1 FY2026Period ended 2025-11-30 | $1,382,729,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-07 |
| Q2 FY2026Period ended 2026-02-28 | $1,495,528,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-08 |
| Q3 FY2026Period ended 2026-05-31 | $1,481,793,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-08 |
| TTM revenue | $5,691,025,000 |
Current P/S: $5,308,010,128 market capitalization ÷ $5,691,025,000 TTM revenue = 0.93x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-05-31): $1.48B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T22:18:25.882Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-08-31 · USD | FY20212021-08-31 · USD | FY20222022-08-31 · USD | FY20232023-08-31 · USD | FY20242024-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|---|
| Foods And Sundries | $1.7B | $1.7B | $1.9B | $2.1B | $2.3B | $2.4B |
| Fresh Foods | $912M | $1.0B | $1.1B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-08-31 · USD | FY20212021-08-31 · USD | FY20222022-08-31 · USD | FY20232023-08-31 · USD | FY20242024-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|---|
| Caribbean Operations Segment | $994M | $1.0B | $1.2B | $1.3B | $1.4B | $1.5B |
| Central American Operations Segment | $1.9B | $2.1B | $2.4B |
$5.69B
$5.69 Billion
+10.18%
vs. $5.17B a year ago (TTM)
+10.08%
5 Year compound annual growth rate
1 Year
+10.18%
3 Year
+9.66%
5 Year
+10.08%
10 Year
+7.00%
15 Year
+8.68%
20 Year
+11.39%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.27B | +$356.20M | +7.25% |
| 2024 | $4.91B | +$502.06M | +11.38% |
| 2023 | $4.41B | +$345.75M | +8.50% |
| 2022 | $4.07B | +$446.22M | +12.33% |
| 2021 | $3.62B | +$290.68M | +8.73% |
| 2020 |
TTM Growth
+10.18%
3-Year CAGR
+9.66%
5-Year CAGR
+10.08%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T22:18:25.882Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.4B |
| $1.6B |
| Hardlines | $345M | $410M | $443M | $454M | $545M | $572M |
|---|
| Health Services | N/A | N/A | N/A | N/A | $44M | $52M |
|---|
| Other Business | $131M | $140M | $180M | $205M | N/A | N/A |
|---|
| Softlines | $147M | $176M | $227M | $231M | $257M | $292M |
|---|
| $3.0B |
| $3.2B |
| Colombia Operations Segment | $366M | $421M | $479M | $440M | $557M | $626M |
|---|
| United States Operations Segment | $74M | $88M | $49M | $32M | $39M | $2.0B |
|---|
| $3.33B |
| +$105.27M |
| +3.27% |
| 2019 | $3.22B | +$57.22M | +1.81% |
| 2018 | $3.17B | +$170.07M | +5.68% |
| 2017 | $3.00B | +$91.45M | +3.15% |
| 2016 | $2.91B | +$102.57M | +3.66% |
